Central and peripheral contribution to the antihypertensive action of indoramin
- 31 May 1975
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 32 (1) , 30-38
- https://doi.org/10.1016/0014-2999(75)90319-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Inhibition of efferent sympathetic nerve activity by 5-hydroxytryptophan and centrally administered 5-hydroxytryptamineNeuropharmacology, 1975
- Influence of heart rate on the reduction of sympathetic outflow produced by L-dopaAmerican Journal of Physiology-Legacy Content, 1974
- Reduction of sympathetic outflow by central administration of L-DOPA, dopamine and norepinephrineNeuropharmacology, 1973
- Activation of the central pathway of the baroreceptor reflex, a possible mechanism of the hypotensive action of clonidineNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1973
- Pharmacologic studies of indoramin in manClinical Pharmacology & Therapeutics, 1972
- A comparison of the cardiovascular actions of indoramin, propranolol, lignocaine, and quinidineCardiovascular Research, 1972
- Quantitative analysis on isolated organs of the autonomic blocking properties of indoramin hydrochloride (Wy 21901)British Journal of Pharmacology, 1972
- An electronic stimulus artifact suppressorElectroencephalography and Clinical Neurophysiology, 1971
- Inhibition of spontaneous sympathetic nerve activity by the antihypertensive agent Wy-8678Neuropharmacology, 1970
- Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 115)European Journal of Pharmacology, 1968